European Archives - Page 14 of 1585 - European Medical Journal

MHRA Reaffirms Childhood Vaccine Safety Amid Autism Concerns

UK medicines regulator highlights evidence from millions of children showing no association between vaccination and autism

Terminal Ileitis on Imaging Rarely Indicates Crohn’s Disease

A 10-year study found that terminal ileitis detected by computed tomography led to a Crohn’s disease diagnosis in only 12.5% of patients.

Early-Life Sugar Restriction Linked to Lower Adult Cancer Risk

Limiting sugar in the first 1,000 days of life may reduce cancer risk and slow biological aging decades later.

EBUS Uncovers Hidden Lung Cancer in High-Risk Patient

A case report highlights the diagnostic challenge of lung cancer in rheumatoid arthritis-associated interstitial lung disease and the potential role of EBUS-TBNA when conventional biopsy carries substantial risk.

The Need for a More Dynamic Risk Assessment in Steatotic Liver Disease

Steatotic liver disease spans overlapping phenotypes, with changing alcohol use and metabolic risks complicating diagnosis and risk assessment.

Adnexal Lesions in Pregnancy: Ultrasound Helps Assess Cancer Risk

A systematic review found ultrasound could reliably assess adnexal lesions in pregnancy, while decidualised endometriomas could mimic malignancy.

Mediterranean Lifestyle Linked to Lower Heart Risk in Type 2 Diabetes

Mediterranean lifestyle adherence linked to lower cardiovascular events and mortality in adults with type 2 diabetes.

Type 2 Diabetes Accelerates Clinical Aortic Stenosis Progression

A nationwide Swedish study found that type 2 diabetes was associated with faster clinical progression of aortic stenosis.

Crohn’s Disease Monocytes Promote Intestinal Inflammation

New data showed that Crohn’s disease monocytes were systemically reprogrammed before intestinal recruitment, with transcriptional and functional changes linked to inflammatory activity.

Deep Learning Speeds Lymph Node Metastasis Detection

A deep learning model detected bladder cancer lymph node metastases with 100% sensitivity while significantly reducing pathologist review time.